Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial

Tim R. Mocking, Lukas H. Haaksma, Tom Reuvekamp, Angèle Kelder, Willemijn J. Scholten, Lok Lam Ngai, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan A. Maertens, Markus G. Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Jacqueline Cloos, Costa Bachas

Open source

DOI: 10.1038/s41375-025-02747-8
Published: 2025-09-03
Container: Leukemia
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41375-025-02747-8,
  title = {Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial},
  author = {Tim R. Mocking and Lukas H. Haaksma and Tom Reuvekamp and Angèle Kelder and Willemijn J. Scholten and Lok Lam Ngai and Dimitri A. Breems and Thomas Fischer and Bjørn T. Gjertsen and Laimonas Griškevičius and Gunnar Juliusson and Johan A. Maertens and Markus G. Manz and Thomas Pabst and Jakob R. Passweg and Kimmo Porkka and Peter J. M. Valk and Patrycja Gradowska and Bob Löwenberg and David C. de Leeuw and Jeroen J. W. M. Janssen and Gert J. Ossenkoppele and Arjan A. van de Loosdrecht and Jacqueline Cloos and Costa Bachas},
  year = {2025},
  journal = {Leukemia},
  doi = {10.1038/s41375-025-02747-8},
  url = {https://doi.org/10.1038/s41375-025-02747-8}
}

RIS

TY  - JOUR
TI  - Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
AU  - Tim R. Mocking
AU  - Lukas H. Haaksma
AU  - Tom Reuvekamp
AU  - Angèle Kelder
AU  - Willemijn J. Scholten
AU  - Lok Lam Ngai
AU  - Dimitri A. Breems
AU  - Thomas Fischer
AU  - Bjørn T. Gjertsen
AU  - Laimonas Griškevičius
AU  - Gunnar Juliusson
AU  - Johan A. Maertens
AU  - Markus G. Manz
AU  - Thomas Pabst
AU  - Jakob R. Passweg
AU  - Kimmo Porkka
AU  - Peter J. M. Valk
AU  - Patrycja Gradowska
AU  - Bob Löwenberg
AU  - David C. de Leeuw
AU  - Jeroen J. W. M. Janssen
AU  - Gert J. Ossenkoppele
AU  - Arjan A. van de Loosdrecht
AU  - Jacqueline Cloos
AU  - Costa Bachas
PY  - 2025
JO  - Leukemia
DO  - 10.1038/s41375-025-02747-8
UR  - https://doi.org/10.1038/s41375-025-02747-8
ER  -

APA

Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Löwenberg, B., Leeuw, D. C. D., Janssen, J. J. W. M., Ossenkoppele, G. J., Loosdrecht, A. A. V. D., Cloos, J., & Bachas, C. (2025). Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial. Leukemia. https://doi.org/10.1038/s41375-025-02747-8

Source records

crossref · retrieved 2026-09-26T04:17:05.135Z